| Literature DB >> 33387989 |
Arzu Karaveli1, Ali Sait Kavaklı1, Murat Özçelik1, Mutlu Ateş2, Kerem İnanoğlu1, Sadık Özmen1.
Abstract
Background/aim: This study aimed to evaluate the effect of low- and high-pressure pneumoperitoneum pressures applied during robotic-assisted laparoscopic prostatectomy (RALP) using near-infrared spectroscopy (NIRS) on regional cerebral oxygenation saturation (rSO2). Materials and methods: The prospective, comparative, and observational study included patients aged 18–80 years, with the American Society of Anesthesiologists (ASA) physical status I-II, who would undergo elective RALP. The patients were divided into two groups (12 mmHg of pneumoperitoneum pressure group, n=22 and 15 mmHg of pneumoperitoneum pressure group, n=23). Patients’ demographic data, durations of anesthesia, surgery, pneumoperitoneum, and Trendelenburg position, intraoperative estimated blood loss, fluid therapy, urine output, hemodynamic and respiratory data, and rSO2 values were recorded at regular intervals.Entities:
Keywords: Near-infrared spectroscopy; pneumoperitoneum; prostatectomy; robotic-assisted surgery; trendelenburg position
Mesh:
Year: 2021 PMID: 33387989 PMCID: PMC8283475 DOI: 10.3906/sag-2005-368
Source DB: PubMed Journal: Turk J Med Sci ISSN: 1300-0144 Impact factor: 0.973
Demographic characteristics of patients.
| Group I (n = 22) | Group II (n = 23) | |
|---|---|---|
| Age (y) | 64.36 (4.86) | 62.95 (5.65) |
| BMI (kg/m2) | 27.74 (3.90) | 28.69 (3.46) |
| ASA physical status, I/II | 3/19 | 5/18 |
| Smoking | 3 (13.6%) | 5 (21.7%) |
| Comorbidity | 16 (72.7%) | 13 (56.5%) |
Data are presented as mean (standard deviation) or the number (percentage). BMI: body mass index, ASA: American Society of Anesthesiology.
Intraoperative data of patients.
| Group I (n = 22) | Group II (n = 23) | P-value | |
|---|---|---|---|
| Fluid therapy (mL) | 1500(1300–2000) | 1600(1500–2000) | 0.126 |
| Urine output (mL) | 350(275–450) | 400(300–400) | 0.729 |
| Estimated blood loss (mL) | 100(100–150) | 100(80–150) | 0.255 |
| Time (min) | |||
| Anesthesia | 252(228–300) | 240(210–270) | 0.399 |
| Surgery | 222(198–267) | 205(180–240) | 0.339 |
| Pneumoperitoneum | 200(170–230) | 175(155–215) | 0.419 |
| Trendelenburg | 180(150–212.5) | 160(130–200) | 0.356 |
Data are presented as median (interquartile range); *P <0.05 is statistically significant.
Regional cerebral oxygenation saturation changes of patients.
| Left rSO2 | Right rSO2 | |||||
|---|---|---|---|---|---|---|
| Group I (n = 22) | Group II (n = 23) | P-value | Group I (n = 22) | Group II (n = 23) | P-value | |
| t1 | 65.54 (9.60) | 65.69 (9.61) | 0.958 | 66.86 (9.64) | 64.69 (8.88) | 0.437 |
| t2 | 63.13 (10.17) a,b,c,d,e | 64.95 (7.13) f,g,h,i,j | 0.794 | 62.50 (10.08)k,l,m,n,o | 62.91 (8.22) p,r,s,t,u | 0.982 |
| t3 | 68.13 (12.26) a* | 70.91 (9.57) f* | 0.633 | 68.54 (9.10) k* | 71.00 (12.19) p* | 0.450 |
| t4 | 69.18 (12.35) b* | 73.43 (8.89) g* | 0.191 | 68.95 (8.45) l* | 70.69 (11.31) r* | 0.563 |
| t5 | 69.27 (10.59) c* | 73.78 (9.219 h* | 0.134 | 69.36 (7.43) m* | 71.17 (11.22) s* | 0.529 |
| t6 | 70.95 (9.76) d* | 73.78 (8.53) i* | 0.306 | 70.68 (6.40) n* | 71.60 (10.91) t* | 0.731 |
| t7 | 70.86 (9.55) e* | 73.60 (11.059 j* | 0.379 | 70.81 (7.62) o* | 71.17 (9.75) u* | 0.893 |
Data are presented as mean (standard deviation); *P <0.05 is statistically significant. rSO2: regional cerebral oxygenation saturation. a P = 0.005 t2 vs t3, b P = 0.001 t2 vs t4, c P = 0.000 t2 vs t5, d P = 0,001 t2 vs t6, e P = 0.000 t2 vs t7, f P = 0.000 t2 vs t3, g P = 0.001 t2 vs t4, h P = 0.002 t2 vs t5, i P = 0.002 t2 vs t6 ,j P = 0.000 t2 vs t7, kP = 0.000 t2 vs t3, l P = 0.000 t2 vs t4, m P = 0.000 t2 vs t5, n P = 0.000 t2 vs t6, o P = 0.002 t2 vs t7, p P = 0.000 t2 vs t3, r P = 0.001 t2 vs t4, s P = 0.001 t2 vs t5, t P = 0.000 t2 vs t6, u P = 0.000 t2 vs t
Hemodynamic findings of patients.
| Group I (n = 22) | Group II (n = 23) | P-value | |
|---|---|---|---|
| Heart rate (beat/min) | |||
| t1 | 76.68 (12.19) | 73.39 (11.87) | 0.364 |
| t2 | 66.59 (17.38) | 64.69 (15.21) | 0.776 |
| t3 | 62.68 (15.42) | 59.82 (10.44) | 0.811 |
| t4 | 59.54 (12.90) | 58.21 (9.28) | 0.820 |
| t5 | 61.54 (12.20) | 60.08 (10.84) | 0.991 |
| t6 | 62.77 (11.59) | 62.08 (13.31) | 0.829 |
| t7 | 63.90 (13.61) | 61.52 (11.38) | 0.526 |
| Mean arterial pressure (mmHg) | |||
| t1 | 88.40 (19.37) | 85.08 (14.99) | 0.522 |
| t2 | 89.77 (21.05) | 97.47 (17.84) | 0.192 |
| t3 | 90.00 (11.33) | 92.60 (10.18) | 0.421 |
| t4 | 81.86 (9.78) | 88.47 (12.13) | 0.051 |
| t5 | 81.95 (8.10) | 86.47 (10.79) | 0.120 |
| t6 | 82.77 (8.50) | 88.95 (11.79) | 0.051 |
| t7 | 70.40 (14.11) | 77.78 (12.45) | 0.070 |
| Pulse oximetry (%) | |||
| t1 | 98.90 (1.34) | 98.78 (1.27) | 0.615 |
| t2 | 98.95 (1.21) | 98.78 (0.99) | 0.384 |
| t3 | 98.68 (1.49) | 98.13 (1.79) | 0.295 |
| t4 | 98.63 (1.43) | 98.17 (1.69) | 0.348 |
| t5 | 98.68 (1.28) | 98.43 (1.30) | 0.444 |
| t6 | 98.63 (1.04) | 98.52 (1.37) | 0.906 |
| t7 | 98.90 (1.01) | 98.60 (1.23) | 0.463 |
Data are presented as mean (standard deviation); *P <0.05 is statistically significant.
Lactate levels of patients.
| Group I (n = 22) | Group II (n = 23) | P-value | |
|---|---|---|---|
| t1 | 1.2 (0.9–1.5) | 1.2 (1–1.7) | 0.793 |
| t2 | 1.1 (1–1.4) | 1.6 (1.1–1.8) | 0.028* |
| t3 | 1.0 (0.8–1.4) | 1.5 (1–1.8) | 0.032* |
| t4 | 1.0 (0.8–1.4) | 1.4 (0.9–1.8) | 0.041* |
| t5 | 1.1 (0.8–1.4) | 1.5 (0.9–1.5) | 0.027* |
| t6 | 1.3 (1–1.6) | 1.6 (1.1–2.0) | 0.351 |
Data are presented as median (interquartile range); *p<0.05 is statistically significant.
Hemoglobin levels of patients.
| Group I (n = 22) | Group II (n = 23) | P-value | |
|---|---|---|---|
| t1 | 13.41 (1.17) | 13.28 (1.30) | 0.782 |
| t2 | 12.44 (1.53) | 13.17 (1.01) | 0.064 |
| t3 | 12.64 (1.64) | 13.16 (0.85) | 0.510 |
| t4 | 12.63 (1.59) | 12.98 (0.99) | 0.380 |
| t5 | 12.63 (1.66) | 12.70 (1.12) | 0.881 |
| t6 | 12.63 (2.18) | 12.94 (1.27) | 0.564 |
Data are presented as mean (standard deviation); *P < 0.05 is statistically significant.